COSMAX NBT, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,935 KRW | -1.87% |
|
+1.55% | -38.71% |
| 2023 | Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. | CI |
| 2023 | Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. | CI |
| Sales 2022 | 328B 237M | Sales 2023 | 334B 241M | Capitalization | 132B 95.41M |
|---|---|---|---|---|---|
| Net income 2022 | -13.07B -9.45M | Net income 2023 | -6.49B -4.69M | EV / Sales 2022 | 0.71 x |
| Net Debt 2022 | 144B 104M | Net Debt 2023 | 144B 104M | EV / Sales 2023 | 0.83 x |
| P/E ratio 2022 |
-6.77
x | P/E ratio 2023 |
-20.4
x | Employees | 525 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.56% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.87% | ||
| 1 week | +1.55% | ||
| Current month | +0.38% | ||
| 1 month | -0.38% | ||
| 3 months | -9.75% | ||
| 6 months | -42.39% | ||
| Current year | -38.71% |
1 week
3 860.00
4 135.00
1 month
3 650.004 450.00
Current year
3 620.007 330.00
1 year
3 620.007 330.00
3 years
3 620.0011 250.00
5 years
2 720.0012 900.00
10 years
2 720.0041 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Won-Il Yoon
CEO | Chief Executive Officer | 59 | 20-12-29 |
Man-Seok Youn
CTO | Chief Tech/Sci/R&D Officer | 58 | 12-07-31 |
Byung-Joo Lee
BRD | Director/Board Member | 45 | 18-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Byung-Joo Lee
BRD | Director/Board Member | 45 | 18-05-31 |
Won-Il Yoon
CEO | Chief Executive Officer | 59 | 20-12-29 |
Yeon-Hong Noh
BRD | Director/Board Member | 69 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-16 | 3,935 | -1.87% | 27,146 |
| 24-07-15 | 4,010 | -0.99% | 19,853 |
| 24-07-12 | 4,050 | +2.53% | 109,793 |
| 24-07-11 | 3,950 | -0.88% | 22,044 |
| 24-07-10 | 3,985 | +2.84% | 23,423 |
End-of-day quote Korea S.E., July 15, 2024
More quotes
COSMAX NBT, INC., formerly NUTRIBIOTECH. CO., LTD., is a company mainly engaged in the manufacturing and sale of health functional foods. The Company is engaged in the research and development of functional raw materials and ingredients, the production and sale of health functional foods and health oriented foods.
Sector
Food Processing
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3,935
KRW
Average target price
10,500
KRW
Spread / Average Target
+166.84%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.71% | 59.64M | |
| +21.64% | 8.68B | |
| -6.80% | 6.71B | |
| -16.77% | 4.97B | |
| -6.11% | 3.66B | |
| -22.96% | 3.08B | |
| -18.62% | 1.13B | |
| -25.62% | 1.13B | |
| -1.51% | 953M | |
| -11.94% | 862M |
- Stock Market
- Equities
- A222040 Stock
